Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Loxl4 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Loxl4 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LOXL4 mRNA | CTD | PMID:36331819 | Loxl4 | Rat | 17beta-estradiol | increases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Estradiol results in increased expression of LOXL4 mRNA | CTD | PMID:21795739|PMID:23019147|PMID:25321415 | Loxl4 | Rat | 17beta-estradiol | multiple interactions | ISO | LOXL4 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of LOXL4 mRNA; [Estradiol co-treated with Progesterone] more ... | CTD | PMID:20660070|PMID:21795739 | Loxl4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Loxl4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of LOXL4 mRNA | CTD | PMID:21570461|PMID:28922406 | Loxl4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LOXL4 mRNA | CTD | PMID:32109520|PMID:33387578 | Loxl4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Loxl4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of LOXL4 mRNA | CTD | PMID:19933214|PMID:27562557 | Loxl4 | Rat | 3-chloropropane-1,2-diol | decreases expression | EXP | | 6480464 | alpha-Chlorohydrin results in decreased expression of LOXL4 mRNA | CTD | PMID:28522335 | Loxl4 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | LOXL4 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Loxl4 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | bisphenol S results in decreased expression of LOXL4 mRNA | CTD | PMID:25912373 | Loxl4 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Loxl4 (Mus musculus) | 6480464 | bisphenol S results in increased expression of LOXL4 mRNA | CTD | PMID:30951980 | Loxl4 | Rat | 5-aza-2'-deoxycytidine | increases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Decitabine results in increased expression of LOXL4 mRNA | CTD | PMID:21856257 | Loxl4 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of LOXL4 mRNA | CTD | PMID:28959563 | Loxl4 | Rat | actinomycin D | increases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Dactinomycin results in increased expression of LOXL4 mRNA | CTD | PMID:38460933 | Loxl4 | Rat | actinomycin D | multiple interactions | ISO | LOXL4 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of LOXL4 mRNA | CTD | PMID:38460933 | Loxl4 | Rat | aflatoxin B1 | increases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of LOXL4 mRNA | CTD | PMID:21641981 | Loxl4 | Rat | aflatoxin B1 | increases methylation | ISO | LOXL4 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of LOXL4 gene | CTD | PMID:27153756 | Loxl4 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of LOXL4 mRNA | CTD | PMID:35163327 | Loxl4 | Rat | arsenous acid | decreases expression | ISO | Loxl4 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of LOXL4 mRNA | CTD | PMID:39716349 | Loxl4 | Rat | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of LOXL4 mRNA | CTD | PMID:36841081 | Loxl4 | Rat | benzo[a]pyrene | multiple interactions | ISO | Loxl4 (Mus musculus) | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to LOXL4 promoter] | CTD | PMID:19654925 | Loxl4 | Rat | benzo[a]pyrene | affects methylation | ISO | LOXL4 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of LOXL4 promoter | CTD | PMID:27901495 | Loxl4 | Rat | benzo[a]pyrene | decreases expression | ISO | Loxl4 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of LOXL4 mRNA | CTD | PMID:19770486 | Loxl4 | Rat | benzo[a]pyrene diol epoxide I | increases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of LOXL4 mRNA | CTD | PMID:26238291 | Loxl4 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of LOXL4 mRNA | CTD | PMID:25181051 | Loxl4 | Rat | bisphenol A | decreases methylation | ISO | LOXL4 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of LOXL4 gene | CTD | PMID:31601247 | Loxl4 | Rat | bisphenol A | decreases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of LOXL4 mRNA | CTD | PMID:33670352 | Loxl4 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of LOXL4 mRNA | CTD | PMID:30816183|PMID:32528016 | Loxl4 | Rat | bisphenol A | increases expression | ISO | Loxl4 (Mus musculus) | 6480464 | bisphenol A results in increased expression of LOXL4 mRNA | CTD | PMID:30951980 | Loxl4 | Rat | bisphenol A | affects expression | ISO | LOXL4 (Homo sapiens) | 6480464 | bisphenol A affects the expression of LOXL4 mRNA | CTD | PMID:30903817 | Loxl4 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of LOXL4 gene | CTD | PMID:28505145 | Loxl4 | Rat | bisphenol AF | decreases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | bisphenol AF results in decreased expression of LOXL4 mRNA | CTD | PMID:25912373 | Loxl4 | Rat | bisphenol F | multiple interactions | ISO | LOXL4 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Loxl4 | Rat | bisphenol F | increases expression | ISO | Loxl4 (Mus musculus) | 6480464 | bisphenol F results in increased expression of LOXL4 mRNA | CTD | PMID:30951980 | Loxl4 | Rat | calcitriol | increases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of LOXL4 mRNA | CTD | PMID:26485663 | Loxl4 | Rat | carbon nanotube | decreases expression | ISO | Loxl4 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of LOXL4 mRNA | CTD | PMID:25620056 | Loxl4 | Rat | carbon nanotube | increases expression | ISO | Loxl4 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in increased expression of LOXL4 mRNA; Nanotubes, Carbon results in increased more ... | CTD | PMID:25554681|PMID:25620056 | Loxl4 | Rat | CGP 52608 | multiple interactions | ISO | LOXL4 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to LOXL4 gene] | CTD | PMID:28238834 | Loxl4 | Rat | chromium(6+) | multiple interactions | ISO | LOXL4 (Homo sapiens) | 6480464 | [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression more ... | CTD | PMID:38479592 | Loxl4 | Rat | cyclosporin A | increases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of LOXL4 mRNA | CTD | PMID:20106945|PMID:21632981 | Loxl4 | Rat | cyclosporin A | decreases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of LOXL4 mRNA | CTD | PMID:27989131 | Loxl4 | Rat | cyclosporin A | affects expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Cyclosporine affects the expression of LOXL4 mRNA | CTD | PMID:25562108 | Loxl4 | Rat | cytarabine | decreases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Cytarabine results in decreased expression of LOXL4 mRNA | CTD | PMID:21198554 | Loxl4 | Rat | dexamethasone | multiple interactions | ISO | LOXL4 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Loxl4 | Rat | diallyl trisulfide | multiple interactions | ISO | LOXL4 (Homo sapiens) | 6480464 | diallyl trisulfide inhibits the reaction [Oxygen deficiency results in increased expression of LOXL4 mRNA] | CTD | PMID:28574600 | Loxl4 | Rat | diarsenic trioxide | decreases expression | ISO | Loxl4 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of LOXL4 mRNA | CTD | PMID:39716349 | Loxl4 | Rat | dibenz[a,h]anthracene | decreases expression | ISO | Loxl4 (Mus musculus) | 6480464 | 1,2,5,6-dibenzanthracene results in decreased expression of LOXL4 mRNA | CTD | PMID:26377693 | Loxl4 | Rat | dichloroacetic acid | decreases expression | ISO | Loxl4 (Mus musculus) | 6480464 | Dichloroacetic Acid results in decreased expression of LOXL4 mRNA | CTD | PMID:28962523 | Loxl4 | Rat | dioxygen | multiple interactions | ISO | LOXL4 (Homo sapiens) | 6480464 | 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Oxygen deficiency results in increased expression of LOXL4 mRNA]; diallyl trisulfide more ... | CTD | PMID:28574600 | Loxl4 | Rat | dioxygen | increases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of LOXL4 mRNA | CTD | PMID:28574600 | Loxl4 | Rat | doxorubicin | decreases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of LOXL4 mRNA | CTD | PMID:22908232 | Loxl4 | Rat | doxorubicin | increases expression | ISO | Loxl4 (Mus musculus) | 6480464 | Doxorubicin results in increased expression of LOXL4 mRNA | CTD | PMID:36227756 | Loxl4 | Rat | doxorubicin | increases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of LOXL4 mRNA | CTD | PMID:30031762 | Loxl4 | Rat | entinostat | increases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | entinostat results in increased expression of LOXL4 mRNA | CTD | PMID:27188386 | Loxl4 | Rat | epoxiconazole | increases expression | ISO | Loxl4 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of LOXL4 mRNA | CTD | PMID:35436446 | Loxl4 | Rat | ethanol | decreases expression | ISO | Loxl4 (Mus musculus) | 6480464 | Ethanol results in decreased expression of LOXL4 mRNA | CTD | PMID:34755883 | Loxl4 | Rat | ethylparaben | increases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | ethyl-p-hydroxybenzoate results in increased expression of LOXL4 mRNA | CTD | PMID:37690743 | Loxl4 | Rat | ferric oxide | increases expression | EXP | | 6480464 | ferric oxide analog results in increased expression of LOXL4 mRNA | CTD | PMID:38615722 | Loxl4 | Rat | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of LOXL4 mRNA | CTD | PMID:24793618 | Loxl4 | Rat | furan | decreases expression | EXP | | 6480464 | furan results in decreased expression of LOXL4 mRNA | CTD | PMID:25539665|PMID:26194646 | Loxl4 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of LOXL4 mRNA | CTD | PMID:33387578 | Loxl4 | Rat | graphene oxide | decreases expression | ISO | Loxl4 (Mus musculus) | 6480464 | graphene oxide analog results in decreased expression of LOXL4 mRNA | CTD | PMID:33227293 | Loxl4 | Rat | hexane | increases methylation | EXP | | 6480464 | n-hexane results in increased methylation of LOXL4 promoter | CTD | PMID:23740543 | Loxl4 | Rat | indometacin | multiple interactions | ISO | LOXL4 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Loxl4 | Rat | inulin | multiple interactions | ISO | Loxl4 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LOXL4 mRNA | CTD | PMID:36331819 | Loxl4 | Rat | lipopolysaccharide | multiple interactions | ISO | LOXL4 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LOXL4 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... | CTD | PMID:35811015 | Loxl4 | Rat | lipopolysaccharide | decreases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of LOXL4 mRNA | CTD | PMID:35811015 | Loxl4 | Rat | medroxyprogesterone acetate | decreases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Medroxyprogesterone Acetate results in decreased expression of LOXL4 mRNA | CTD | PMID:20843944 | Loxl4 | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of LOXL4 mRNA | CTD | PMID:24810058 | Loxl4 | Rat | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of LOXL4 mRNA | CTD | PMID:28801915 | Loxl4 | Rat | Nutlin-3 | multiple interactions | ISO | LOXL4 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of LOXL4 mRNA | CTD | PMID:38460933 | Loxl4 | Rat | orphenadrine | affects expression | EXP | | 6480464 | Orphenadrine affects the expression of LOXL4 mRNA | CTD | PMID:23665939 | Loxl4 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of LOXL4 mRNA | CTD | PMID:33387578 | Loxl4 | Rat | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of LOXL4 mRNA | CTD | PMID:32680482 | Loxl4 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Loxl4 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LOXL4 mRNA; [perfluorooctane sulfonic more ... | CTD | PMID:36331819 | Loxl4 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of LOXL4 mRNA | CTD | PMID:35163327 | Loxl4 | Rat | phenformin | increases expression | EXP | | 6480464 | Phenformin results in increased expression of LOXL4 mRNA | CTD | PMID:31324951 | Loxl4 | Rat | phenobarbital | affects expression | ISO | Loxl4 (Mus musculus) | 6480464 | Phenobarbital affects the expression of LOXL4 mRNA | CTD | PMID:23091169 | Loxl4 | Rat | potassium dichromate | decreases expression | ISO | Loxl4 (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of LOXL4 mRNA | CTD | PMID:23608068 | Loxl4 | Rat | progesterone | multiple interactions | ISO | LOXL4 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of LOXL4 mRNA; [Estradiol co-treated with Progesterone] more ... | CTD | PMID:20660070|PMID:21795739 | Loxl4 | Rat | progesterone | decreases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Progesterone results in decreased expression of LOXL4 mRNA | CTD | PMID:20864642 | Loxl4 | Rat | propanal | increases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of LOXL4 mRNA | CTD | PMID:26079696 | Loxl4 | Rat | resveratrol | multiple interactions | ISO | LOXL4 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of LOXL4 mRNA | CTD | PMID:23557933 | Loxl4 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | LOXL4 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LOXL4 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... | CTD | PMID:35811015 | Loxl4 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | decreases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | S-(1,2-dichlorovinyl)cysteine results in decreased expression of LOXL4 mRNA | CTD | PMID:35811015 | Loxl4 | Rat | silicon dioxide | decreases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of LOXL4 mRNA | CTD | PMID:25895662 | Loxl4 | Rat | sodium arsenite | increases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of LOXL4 mRNA | CTD | PMID:34032870|PMID:39719251 | Loxl4 | Rat | sodium arsenite | decreases expression | ISO | Loxl4 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of LOXL4 mRNA | CTD | PMID:37682722 | Loxl4 | Rat | sunitinib | decreases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of LOXL4 mRNA | CTD | PMID:31533062 | Loxl4 | Rat | tetrachloromethane | affects expression | ISO | Loxl4 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of LOXL4 mRNA | CTD | PMID:17484886 | Loxl4 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of LOXL4 mRNA | CTD | PMID:23411599 | Loxl4 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of LOXL4 mRNA | CTD | PMID:34492290 | Loxl4 | Rat | titanium dioxide | decreases methylation | ISO | Loxl4 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of LOXL4 gene; titanium dioxide results in decreased methylation more ... | CTD | PMID:35295148 | Loxl4 | Rat | tributylstannane | decreases expression | ISO | Loxl4 (Mus musculus) | 6480464 | tributyltin results in decreased expression of LOXL4 mRNA | CTD | PMID:31939706 | Loxl4 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of LOXL4 mRNA | CTD | PMID:33387578 | Loxl4 | Rat | Triptolide | increases expression | ISO | Loxl4 (Mus musculus) | 6480464 | triptolide results in increased expression of LOXL4 mRNA | CTD | PMID:32835833 | Loxl4 | Rat | urethane | decreases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Urethane results in decreased expression of LOXL4 mRNA | CTD | PMID:28818685 | Loxl4 | Rat | valproic acid | increases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of LOXL4 mRNA | CTD | PMID:23179753 | Loxl4 | Rat | valproic acid | decreases expression | ISO | LOXL4 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of LOXL4 mRNA | CTD | PMID:29154799 | | |||||||||






















